Evaluating Compliance and Performance of 0.5 mL AD Syringes: A Global Standards Review

Akash Sharma, Chandra Prakash, Ankur Vora
{"title":"Evaluating Compliance and Performance of 0.5 mL AD Syringes: A Global Standards Review","authors":"Akash Sharma, Chandra Prakash, Ankur Vora","doi":"10.9734/jamps/2024/v26i8705","DOIUrl":null,"url":null,"abstract":"Background: This research delves into the comprehensive evaluation of AD 0.5 ml syringes, crucial components in medical procedures. These syringes fall into the category of class IIa according to EUMDR and are classified as class II by USFDA. The focus is on assessing their compliance with regulatory standards such as the European Medical Device Regulation (EUMDR), International Organization for Standardization (ISO 13485), US Food and Drug Administration (USFDA), and guidelines from the Medical Device Single Audit Program (MDSAP). The study particularly scrutinizes the design, manufacturing, and performance aspects of these syringes, aligning with the rigorous requirements set by these regulatory bodies. \nMethods: This single-arm observational study involved distributing 8,000 syringes to 52 hospitals across 8 counties in Kenya, healthcare personnel used the syringes on 2,714 patients. Data collection utilized a single usability feedback form comprising quantitative and qualitative questionnaires. Quantitative data included counts of syringes used, failed inspection checks, and device failures. Qualitative data focused on usability parameters such as protection and sterility, preparation, injection, and reuse/safety and disposal, rated on a scale from 1 to 5. Healthcare professionals eligible for the qualitative questionnaire had used the syringe on a minimum of 50 patients. \nResults: The study evaluated the usability and customer satisfaction of the 0.5 mL Auto Disable Early Activation syringe from Revital Healthcare (EPZ) Limited. Quantitative analysis showed that all syringes performed as intended, with 0% failing during use. Quantitative analysis revealed no syringes failed during use, indicating a 0.0% failure rate. Qualitative feedback highlighted high ratings in usability tasks, including protection and sterility (97.78%), preparation (95.56%), injection (94.81%), and reuse/safety and disposal (95.93%). Overall customer satisfaction was rated positively, with an 87.78% satisfaction rate. Overall, the syringe received positive feedback for usability and customer satisfaction, highlighting its effectiveness and safety in medical procedures. Usability ratings, measured on a 5-point Likert scale (1 = Poor, 2 = Fair, 3 = Good, 4 = Very Good, 5 = Excellent), further support the syringe’s efficacy and safety. Both quantitative and qualitative analyses confirmed that none of the tested syringes exhibited performance failures, indicating no quality or reliability concerns with the product. \nConclusion: The findings of this research underscore the paramount importance of adherence to international standards in the design, manufacturing, and performance of AD 0.5 ml syringes. The emphasis on compliance with regulatory guidelines enhances the reliability and safety of these syringes, instilling confidence among manufacturers, healthcare professionals, and regulatory bodies. As the healthcare industry evolves, this research contributes to the ongoing dialogue on medical device assessment and compliance. Ultimately, the paper aims to promote improved patient safety and outcomes on a global scale, emphasizing the critical role of adherence to international standards in the ever-changing landscape of healthcare.","PeriodicalId":14903,"journal":{"name":"Journal of Advances in Medical and Pharmaceutical Sciences","volume":"13 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Advances in Medical and Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9734/jamps/2024/v26i8705","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: This research delves into the comprehensive evaluation of AD 0.5 ml syringes, crucial components in medical procedures. These syringes fall into the category of class IIa according to EUMDR and are classified as class II by USFDA. The focus is on assessing their compliance with regulatory standards such as the European Medical Device Regulation (EUMDR), International Organization for Standardization (ISO 13485), US Food and Drug Administration (USFDA), and guidelines from the Medical Device Single Audit Program (MDSAP). The study particularly scrutinizes the design, manufacturing, and performance aspects of these syringes, aligning with the rigorous requirements set by these regulatory bodies. Methods: This single-arm observational study involved distributing 8,000 syringes to 52 hospitals across 8 counties in Kenya, healthcare personnel used the syringes on 2,714 patients. Data collection utilized a single usability feedback form comprising quantitative and qualitative questionnaires. Quantitative data included counts of syringes used, failed inspection checks, and device failures. Qualitative data focused on usability parameters such as protection and sterility, preparation, injection, and reuse/safety and disposal, rated on a scale from 1 to 5. Healthcare professionals eligible for the qualitative questionnaire had used the syringe on a minimum of 50 patients. Results: The study evaluated the usability and customer satisfaction of the 0.5 mL Auto Disable Early Activation syringe from Revital Healthcare (EPZ) Limited. Quantitative analysis showed that all syringes performed as intended, with 0% failing during use. Quantitative analysis revealed no syringes failed during use, indicating a 0.0% failure rate. Qualitative feedback highlighted high ratings in usability tasks, including protection and sterility (97.78%), preparation (95.56%), injection (94.81%), and reuse/safety and disposal (95.93%). Overall customer satisfaction was rated positively, with an 87.78% satisfaction rate. Overall, the syringe received positive feedback for usability and customer satisfaction, highlighting its effectiveness and safety in medical procedures. Usability ratings, measured on a 5-point Likert scale (1 = Poor, 2 = Fair, 3 = Good, 4 = Very Good, 5 = Excellent), further support the syringe’s efficacy and safety. Both quantitative and qualitative analyses confirmed that none of the tested syringes exhibited performance failures, indicating no quality or reliability concerns with the product. Conclusion: The findings of this research underscore the paramount importance of adherence to international standards in the design, manufacturing, and performance of AD 0.5 ml syringes. The emphasis on compliance with regulatory guidelines enhances the reliability and safety of these syringes, instilling confidence among manufacturers, healthcare professionals, and regulatory bodies. As the healthcare industry evolves, this research contributes to the ongoing dialogue on medical device assessment and compliance. Ultimately, the paper aims to promote improved patient safety and outcomes on a global scale, emphasizing the critical role of adherence to international standards in the ever-changing landscape of healthcare.
评估 0.5 毫升 AD 注射器的合规性和性能:全球标准回顾
背景:本研究深入探讨了对 AD 0.5 ml 注射器的综合评估,这些注射器是医疗程序中的关键部件。根据《欧洲医疗器械法规》(EUMDR),这些注射器属于 IIa 类,被美国食品药物管理局列为 II 类。重点是评估它们是否符合欧洲医疗器械法规 (EUMDR)、国际标准化组织 (ISO 13485)、美国食品药品管理局 (USFDA) 等监管标准以及医疗器械单一审核计划 (MDSAP) 的指导方针。本研究特别对这些注射器的设计、制造和性能方面进行了审查,以符合这些监管机构的严格要求。研究方法这项单臂观察性研究向肯尼亚 8 个县的 52 家医院分发了 8000 支注射器,医护人员在 2714 名患者身上使用了这些注射器。数据收集使用了由定量和定性问卷组成的单一可用性反馈表。定量数据包括使用的注射器数量、未通过的检查和设备故障。定性数据侧重于可用性参数,如保护和无菌、准备、注射、重复使用/安全和处置,评分范围为 1 到 5 分。符合定性问卷调查条件的医护人员至少为 50 名患者使用过注射器。研究结果该研究评估了 Revital Healthcare (EPZ) Limited 生产的 0.5 mL 自动停用早期激活注射器的可用性和客户满意度。定量分析显示,所有注射器的性能均符合预期,0% 的注射器在使用过程中出现故障。定量分析显示,没有注射器在使用过程中发生故障,故障率为 0.0%。定性反馈显示,在保护和无菌(97.78%)、准备(95.56%)、注射(94.81%)以及重复使用/安全和处置(95.93%)等可用性任务方面的评分较高。客户的总体满意度为 87.78%。总体而言,注射器在可用性和客户满意度方面获得了积极反馈,突出了其在医疗程序中的有效性和安全性。可用性评分采用 5 点李克特量表(1 = 差,2 = 一般,3 = 好,4 = 很好,5 = 极佳),进一步证明了注射器的有效性和安全性。定量和定性分析均证实,所测试的注射器均未出现性能故障,表明产品不存在质量或可靠性问题。结论这项研究结果强调了在设计、制造 AD 0.5 毫升注射器和提高其性能时遵守国际标准的重要性。强调遵守监管准则可提高这些注射器的可靠性和安全性,增强制造商、医疗保健专业人员和监管机构的信心。随着医疗保健行业的不断发展,这项研究将为正在进行的医疗器械评估和合规性对话做出贡献。本文的最终目的是在全球范围内促进患者安全和治疗效果的改善,强调在不断变化的医疗保健行业中遵守国际标准的关键作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信